DXCM vs NBIX
Dexcom vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | DXCM | NBIX |
|---|---|---|
| AI Score | 58 | 66 |
| Price | $71.54 | $175.67 |
| P/E Ratio | 29.81× | 26.20× |
| ROE | 0.3% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 1.0% |
| Debt / Equity | 0.47× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 42.5 | 56.8 |
| Beta | 1.453 | 0.386 |
| Expected Upside | +0.7% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DXCM Full Analysis
NBIX Full Analysis